BamSEC and AlphaSense Join Forces
Learn More

Kite Pharma, Inc.

Formerly NASDAQ: KITE

Indentures Filter

EX-4.8
from S-3ASR 19 pages Kite Pharma, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Kite Pharma, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3ASR 22 pages Kite Pharma, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Kite Pharma, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3ASR 21 pages Kite Pharma, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Kite Pharma, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3ASR 55 pages Kite Pharma, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20 Debt Securities
12/34/56
EX-4.1
from S-1/A 2 pages Delaware Seal 2009 Corporate Kite Pharma, Inc. Chief Operating Officer and Chief Financial Officer This Certifies That Is the Record Holder of Incorporated Under the Laws of the State of Delaware See Reverse for Certain Definitions Cusip 49803l 10 9 Fully Paid and Nonassessable Shares of Common Stock, $0.001 Par Value, Per Share, of Kite Pharma, Inc. Transferable on the Books of the Corporation in Person or by Duly Authorized Attorney Upon Surrender of This Certificate Properly Endorsed. This Certificate Is Not Valid Until Countersigned by the Transfer Agent and Registered by the Registrar. Witness the Facsimile Seal of the Corporation and the Facsimile Signatures of Its Duly Authorized Officers. Dated: Countersigned and Registered: American Stock Transfer & Trust Company, LLC (Brooklyn, Ny) Transfer Agent and Registrar By: Authorized Signature Kite Pharma, Inc. Kp Chairman, President and Chief Executive Officer
12/34/56
EX-4.2
from S-1 70 pages Kite Pharma, Inc. Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4
from DRS 87 pages Kite Pharma, Inc. Investors’ Rights Agreement
12/34/56